Despite the absence of other autoimmune manifestation, typical of thymoma (eg, myasthenia gravis), the patient produced anti-IFN-α and anti-IFN-ω autoantibodies, which contributed to the severe evolution of SARS-CoV-2 infection and might have favored invasive WNV infection. This evidence concerns the gene IFNA1 and myasthenia gravis.